ARCHIVES

FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225.

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Cell Phone Radiation Does Not Raise Child’s Risk of Tumors

August 26, 2011

Cost To Oncologist For Enrolling a Patient On Trial About $2,000, ASCO Survey Finds

June 11, 1999

Prostate Cancer: NIH “Misjudged” Time Needed To Write a Plan, Varmus Says

April 30, 1999

In Brief: Conferees Ok NCI Appropriations At $691.7 Million; Final Amount Available Won’t Be Set Until Spring

November 29, 1974

In the States: Michigan to Allocate $50 Million Annually To Life Sciences

July 23, 1999

NCI Cooperative Group Clinical Trials Approved

August 28, 2009